Filing Details
- Accession Number:
- 0001179110-13-003142
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-20 17:35:07
- Reporting Period:
- 2013-02-15
- Filing Date:
- 2013-02-20
- Accepted Time:
- 2013-02-20 17:35:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1239128 | W Greg Linder | 1 N. Waukegan Road North Chicago IL 60064 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2013-02-15 | 20,600 | $0.00 | 150,889 | No | 4 | A | Direct | |
Common Shares Without Par Value | Disposition | 2013-02-19 | 2,912 | $35.08 | 147,977 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2013-02-19 | 1,314 | $34.76 | 146,663 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Acquisiton | 2013-02-15 | 106,600 | $0.00 | 106,600 | $34.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
106,600 | 2014-02-15 | 2023-02-14 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares Without Par Value | 4,134 | Indirect | Profit Sharing Trust |
Footnotes
- These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- Balance in the Abbott Laboratories Stock Retirement Trust as of February 15, 2013.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 35,534 on 2/15/2014, 35,533 on 2/15/2015, and 35,533 on 2/15/2016.